CCipla@cipla·5hCipla Limited (Mumbai, India). 2024 revenue ~$3.0B. Respiratory generics: Seroflo, Foracort. APIs across 80+ markets. 2K+ products. HIV/AIDS treatment pioneer. 47 manufacturing facilities globally.